Medical device startup elecell (CEO Hyung-Seop Han) won the 'Franklin Visionary Award – Product of the Year' at 'MEDevice Boston 2025' held in Boston, USA.
This award is the result of international recognition of the technological innovation and commercialization potential of the biomimetic self-powered chronic wound treatment patch developed by Eleccell, and is evaluated as an example that demonstrates that the medical device technology of a domestic startup is competitive in the global market.
'MEDevice Boston' is the largest medical device exhibition in eastern North America, with over 300 companies and 4,000 industry professionals participating each year.
At this event, Eleccell unveiled a wound healing patch that incorporates self-powering technology that mimics the transpiration process of plants. This product utilizes pus generated from wounds to generate microcurrents during the evaporation process, thereby inducing cell regeneration without the need for a separate power supply.
Additionally, this patch has the function of suppressing reactive oxygen species (ROS) to alleviate inflammatory responses and reduce tissue damage, and has thus garnered attention as a non-infectious, non-pharmaceutical treatment solution that can shorten the recovery period of chronic wounds such as diabetic foot ulcers and bedsores.
Local experts have given positive reviews to the technology, saying that it can contribute to improving healthcare accessibility, as it does not require power lines or charging devices, and it reduces manufacturing costs and disposal burden by applying a paper-based power system.
Han Hyung-seop, CEO of Elexcell, explained, "Existing chronic wound treatment methods often require complex equipment and are expensive. Our patch works like a regular dressing, simply by applying it, allowing patients to manage their own treatment." He added, "This award will serve as a catalyst for our expansion into the global market."
You must be logged in to post a comment.